Huai Hua San (Sophora Japonica Flower Powder)

Actions

Indications

Western Uses:

• What is Huai Hua San used for in modern practice?

  In modern practice Huai Hua San is referenced for bright-red lower-gastrointestinal bleeding — a traditional pattern that practitioners have applied to presentations such as bleeding internal or external hemorrhoids, anal fissure bleeding, and hematochezia (blood in the stool), and that contemporary lab research has explored in connection with ulcerative colitis, where Western medicine also recognizes inflamed, bleeding bowel mucosa.

  These biomedical correlates are offered as a reference to the formula’s traditional use, not as a claim that it treats any diagnosed disease. Direct human clinical-trial evidence for the formula is limited; the available PubMed-indexed research is largely mechanistic (see research). Any use for rectal bleeding, hemorrhoids, or colitis belongs with a qualified practitioner and appropriate medical evaluation — rectal bleeding always warrants a proper diagnosis to rule out serious causes.

  Source: traditional-use correlates summarized from Bensky & Barolet, Formulas & Strategies; reference only, not a treatment claim.

Originally Appeared In:

• Formulas of Universal Benefit from My Practice (Pu Ji Ben Shi Fang)

Notes:

• How is Huai Hua San different from Huang Tu Tang and Chi Xiao Dou Dang Gui San?

  Huai Hua San treats intestinal bleeding from heat; Huang Tu Tang treats intestinal bleeding from cold and deficiency — the two sit at opposite ends of the same symptom (blood in the stool) and should not be confused. Chi Xiao Dou Dang Gui San overlaps in treating intestinal-wind bleeding and hemorrhoids but is built for a damp-heat-toxin pattern with a stronger tendency toward abscess or suppuration.

  • vs Huang Tu Tang: choose Huang Tu Tang instead when the blood is pale or dusky, the abdomen is cold, and there are clear signs of Spleen-yang deficiency rather than heat — a chronic, deficient bleeding pattern.
  • vs Chi Xiao Dou Dang Gui San: both address chang feng (intestinal wind) and hemorrhoidal bleeding; Chi Xiao Dou Dang Gui San is favored when there is more pronounced damp-heat toxin with swelling or a tendency toward abscess, while Huai Hua San is the more general formula for bright-red bleeding from wind-heat/damp-heat.

  Preparation note: both Huai Hua and Jing Jie Sui are charred (chao tan) in this formula — a classic TCM processing method that increases an herb’s astringent, hemostatic action, which is why Sacred Lotus sources & references and traditional sources specify the charred form for these two herbs rather than the raw herb.

  Source: Bensky & Barolet, Formulas & Strategies (comparison and processing notes for formulas that clear heat and stop bleeding).

Clinical Studies & Research:

• Is there modern research on Huai Hua San?

  Yes, but it is preclinical — network-pharmacology and cell/animal studies exploring how the formula may act on inflamed bowel tissue, plus herb-level pharmacology on its key flower ingredient. Two related 2021 studies used network pharmacology (predicting the formula’s active compounds and likely molecular targets) combined with laboratory validation to propose mechanisms for Huai Hua San in ulcerative colitis, an inflammatory bowel condition that also involves rectal bleeding. Neither is a human clinical trial of the formula.

  • Ulcerative colitis mechanism (preclinical): network pharmacology plus experimental validation proposed anti-inflammatory pathways for Huai Hua San’s active compounds (PMID 34118340).
  • Ulcerative colitis mechanism (preclinical): a separate network-pharmacology and molecular-docking study identified quercetin, luteolin, and nobiletin as candidate active compounds acting via the PI3K-AKT signaling pathway (PMID 34349502).
  • Herb-level pharmacology (review): a review of Sophora japonica (Huai Hua) phytochemistry and pharmacology documents its traditional use for hemorrhoids and the capillary-stabilizing, hemostatic properties of its flavonoids (rutin, quercetin) — context for the chief herb, not a formula-level trial (PMID 27085938).

  Sources: PubMed 34118340; PubMed 34349502; PubMed 27085938. Research context, not a therapeutic claim; direct human clinical-trial evidence for the whole formula remains limited/unverified and is not cited here.